To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

INADcure Foundation


PO Box 11232
Fairfield, NJ 07004 USA

Email Address

[email protected]


The INADcure Foundation is a 501(c)(3) nonprofit organization, EIN 81-4763783, whose mission is to support the development of treatments, including a cure, for Infantile Neuroaxonal Dystrophy (INAD) and other forms of PLA2G6-related neurodegeneration (PLAN). It is estimated that only 150 - 250 children are living with INAD worldwide. Currently, there is no cure, and there are no effective treatments to slow or stop the progression of the disease. The INADcure Foundation is working to change that. Our mission is to raise funds to support the development of treatments and advance a cure for INAD. We collaborate with scientific advisors to identify the most promising INAD research projects for funding. We are tirelessly forging partnerships with academic institutions, biotechnology, and pharmaceutical companies to accelerate the development of new treatments. In addition, we educate the public about INAD and other forms of PLA2G6-related neurodegeneration, advocate for improved access to treatment, and provide support to the families and caregivers of children diagnosed with INAD around the world.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.